Immunosuppressive Properties of Mesenchymal Stem Cells Derived from Bone Marrow of Patients with Chronic Myeloid Leukemia

REFERENCES

• Aggarwal S., Pittenger M. F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005; 105: 1815–1822
   PubMed Web of Science ®Google Scholar
• Bartholomew A., Sturgeon C., Siatskas M., Ferrer K., McIntosh K., Patil S., et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp. Hematol. 2002; 30: 42–48
   PubMed Web of Science ®Google Scholar
• de Klein A., van Kessel A. G., Grosveld G., Bartram C. R., Hagemeijer A., Bootsma D. A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukemia. Nature 1982; 23: 765–767
   Web of Science ®Google Scholar
• Devine S. M., Hoffman R. Role of mesenchymal stem cells in hematopoietic stem cell transplantation. Curr. Opin. Hematol. 2000; 7: 385–363
   Web of Science ®Google Scholar
• Di Nicola M., Carlo-Stella C., Magni M., Milanesi M., Longoni P. D., Matteucci P., et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002; 99: 3838–3843
   PubMed Web of Science ®Google Scholar
• Eliopoulos N., Stagg J., Lejeune L., Pommey S., Galipeau J. Allogeneic marrow stromal cells are immune rejected by MHC class I– and class II–mismatched recipient mice. Blood 2005; 106: 4057–4065
   PubMed Web of Science ®Google Scholar
• Jiang Y., Jahagirdar B. N., Reinhardt R. L., Schwartz R. E., Keene C. D., Ortiz-Gonzalez X. R., et al. Pluripotency of mesenchymal stem cell derived from adult marrow. Nature 2002; 418: 41–49
   PubMed Web of Science ®Google Scholar
• Krampera M., Glennie S., Dyson J., Scott D., Laylor R., Simpson E., et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 2003; 101: 3722–3729
   PubMed Web of Science ®Google Scholar
• Kuroiwa T., Kakishita E., Hamano T., Kataoka Y., Seto Y., Iwata N., et al. Hepatocyte growth factor ameliorates acute graft-versus-host disease and promotes hematopoietic function. J. Clin. Invest. 2001; 107: 1365–1373
   PubMed Web of Science ®Google Scholar
• Lazarus H., Curtin P., Devine S., Curtin P., Maziarz R. T., Holland H. K., et al. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol. Blood Marrow Tr. 2005; 11: 389–398
   PubMed Web of Science ®Google Scholar
• Le Blanc K. Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy 2003; 5: 485–489
   PubMed Web of Science ®Google Scholar
• Le Blanc K., Rasmusson I., Götherström C., Seidel C., Sundberg B., Sundin M., et al. Mesenchymal stem cells inhibit the expression of CD25 (Interleukin-2 Receptor) and CD38 on phytohaemagglutinin-activated lymphocytes. Scand. J. Immunol. 2004; 60: 307–315
   PubMed Web of Science ®Google Scholar
• Le Blanc K., Rasmusson I., Sundberg B., Gotherstrom C., Hassan M., Uzunel M., et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004; 363: 1439–1441
   PubMed Web of Science ®Google Scholar
• Le Blanc K., Tammik C., Rosendahl K., Zetterberg E., Ringden O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp. Hematol. 2003; 31: 890–896
   PubMed Web of Science ®Google Scholar
• Majumdar M. K., Thiede M. A., Hayneseorth S. E., Haynesworth S. E., Bruder S. P., Gerson S. L. Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. J. Hemtother. Stem Cell Res. 2000; 9: 841–848
   PubMedGoogle Scholar
• McIntosh K. R., Bartholomew A. Stromal cell modulation of the immune system: a potential role for mesenchymal stem cells. Graft 2000; 3: 324–328
   Google Scholar
• Meisel R., Zibert A., Laryea M., Gobel U., Daubener W., Dilloo D. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 2004; 103: 4619–4621
   PubMed Web of Science ®Google Scholar
• Noort W. A., Kruisselbrink A. B., in't Anker P. S., Kruger M., van Bezooijen R. L., de Paus R. A., et al. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34 (+) cells in NOD/SCID mice. Exp. Hematol. 2002; 30: 870–878
   PubMed Web of Science ®Google Scholar
• Pittenger M. F., Mackay A. M., Beck S. C., Jaiswal R. K., Douglas R., Mosca J. D. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143–147
   PubMed Web of Science ®Google Scholar
• Rowley J. D. A new consistent chromosome abnormality in chronic myelogenous leukemia. Nature 1973; 243: 290–293
   PubMed Web of Science ®Google Scholar
• Sayegh M. H., Carpenter C. B. Transplantation 50 years later—progress, challenges, and promises. N. Engl. J. Med. 2004; 351: 2761–2766
   PubMed Web of Science ®Google Scholar
• Sato K., Ozaki K., Oh I., Meguro A., Hatanaka K., Nagai T., et al. Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood 2007; 109: 228–234
   PubMed Web of Science ®Google Scholar
• Tse W. T., Pendleton J. D., Beyer W. M., Egalka M. C., Guinan E. C. Suppression of allogeneic T-cell proliferation by human marrow stromal cells:Implications in transplantation. Transplantation 2003; 75: 389–397
   PubMed Web of Science ®Google Scholar
• Zhao Z. G., Tang X. Q., You Y., Li W. M., Liu F., Zou P. Assessment of bone marrow mesenchymal stem cell biological characteristics and support hemotopoiesis function in patients with chronic myeloid leukemia. Leukemia Res. 2006; 30: 993–1003, 2006
   PubMed Web of Science ®Google Scholar